David M Chambers
Overview
Explore the profile of David M Chambers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chambers D, Roberson B, Woodruff C, Blount B, Bhandari D
Chem Res Toxicol
. 2025 Feb;
PMID: 39978418
Exposure assessment of hazardous volatile organic compounds (VOCs) requires accurate quantification of internal dose when establishing limits or identifying significant differences within and among populations. Even though accurate internal dose...
2.
Sergeant C, Sexton E, Moore J, Westwood A, Nagorski S, Ebersole J, et al.
Sci Adv
. 2022 Jul;
8(26):eabn0929.
PMID: 35776798
Mining provides resources for people but can pose risks to ecosystems that support cultural keystone species. Our synthesis reviews relevant aspects of mining operations, describes the ecology of salmonid-bearing watersheds...
3.
Chambers D, Edwards K, Sanchez E, Reese C, Fernandez A, Blount B, et al.
ACS Omega
. 2021 May;
6(19):12684-12690.
PMID: 34056420
A method to achieve accurate measurement of unmetabolized volatile organic compounds (VOCs) in urine was developed and characterized. The method incorporates a novel preanalytical approach of adding isotopically labeled internal...
4.
Kenwood B, Bagchi P, Zhang L, Zhu W, Chambers D, Blount B, et al.
Environ Sci Pollut Res Int
. 2021 Jan;
28(13):16781-16791.
PMID: 33398732
Methylcarbamoyl mercapturic acid (MCAMA, N-acetyl-S-(N-methylcarbamoyl)-L-cysteine) is a urinary metabolite of N,N-dimethylformamide and methyl isocyanate, which are volatile organic compounds that are harmful to humans. N,N-dimethylformamide exposure causes liver damage, and...
5.
De Jesus V, Chambers D, Reese C, Braselton M, Espinosa P, Corstvet J, et al.
Rapid Commun Mass Spectrom
. 2020 Jul;
34(19):e8898.
PMID: 32672382
Rationale: Over 2700 e-cigarette, or vaping, product use-associated lung injury (EVALI) cases were reported to the Centers for Disease Control and Prevention (CDC) during August 2019-February 2020. Bronchoalveolar lavage (BAL)...
6.
Sexton E, Sergeant C, Moore J, Westwood A, Chambers D, McPhee M, et al.
Science
. 2020 Apr;
368(6489):376-377.
PMID: 32327591
No abstract available.
7.
Chambers D, Akulian J, Ghosh S, MacRosty C, Belanger A, Long J, et al.
J Bronchology Interv Pulmonol
. 2019 Oct;
26(4):e50-e52.
PMID: 31569102
No abstract available.
8.
Belanger A, Burks A, Chambers D, Ghosh S, MacRosty C, Conterato A, et al.
J Bronchology Interv Pulmonol
. 2018 Sep;
26(1):41-48.
PMID: 30179920
Background: Electromagnetic navigation (EMN) has improved bronchoscopic access to peripheral pulmonary nodules. A novel EMN system utilizing novel tip-tracked instruments for endobronchial [electromagnetic navigation bronchoscopy (ENB)] as well as transthoracic...
9.
Bhandari D, Bowman B, Patel A, Chambers D, De Jesus V, Blount B
J Chromatogr B Analyt Technol Biomed Life Sci
. 2018 Mar;
1083:86-92.
PMID: 29524697
This work describes a quantitative high-throughput analytical method for the simultaneous measurement of small aliphatic nitrogenous biomarkers, i.e., 1,6-hexamethylenediamine (HDA), isophoronediamine (IPDA), β-methylamino-l-alanine (BMAA), and trimethylamine N-oxide (TMAO), in human...
10.
Werder E, Gam K, Engel L, Kwok R, Ekenga C, Curry M, et al.
J Expo Sci Environ Epidemiol
. 2017 Dec;
28(4):358-370.
PMID: 29288257
To address concerns among Gulf Coast residents about ongoing exposures to volatile organic compounds, including benzene, toluene, ethylbenzene, o-xylene, and m-xylene/p-xylene (BTEX), we characterized current blood levels and identified predictors...